Drawing for HELSINN BUILDING QUALITY CANCER CARE TOGETHER

USPTO serial 79202865

HELSINN BUILDING QUALITY CANCER CARE TOGETHER

Reviewed by CopyMark Law Group

Reg. 5372161Status 709
Filing date
Status date
Registration date
Jan 9, 2018
Examiner
TRUSILO, KELLY JEAN
Law office
Historical data usage

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HELSINN BUILDING QUALITY CANCER CARE TOGETHER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Amanda Laura Nye

Amanda Laura Nye AMANDA NYE LAW OFFICES6 Davis Drive, Suite EBelvedere Tiburon, CA 94920United States

Goods and services

ClassDescriptionStatusFirst use
001[ Chemical substances, namely, chemical compounds for analyses in laboratories for scientific purposes, other than for medical or veterinary use ]SECTION 71 - CANCELLED—
005Pharmaceutical products, namely, anti-inflammatory drugs, antiemetic drugs, [ drugs for the treatment of cancer, carcinoma, leukemia, lymphoma, melanoma, anti-tumor drugs, ] anti-emetic, anti-tumor and anticancer pharmaceutical preparations for the treatment of oncological diseases and the side effects of treatment [ ; drugs for use in case of ulcerative and inflammatory conditions, anti-anxiety drugs, anti-migraine drugs, cognition enhancing drugs, drugs for the prevention and treatment of gastroenterological, hepatologic, nephrologic and cardiovascular disorders of any origin; drugs for internal cleansing purposes, bowel cleansers and evacuants for medical and pharmaceutical purposes, veterinary vaccines and sanitary preparations for medical purposes; dietetic foods adapted for medical use ]SECTION 71 - CANCELLED—
035[ The bringing together, for the benefit of others, of a variety of goods, namely, chemical substances, chemical materials and chemical products, pharmaceutical products, sanitary products for medical purposes, dietetic substances for medical use, excluding the transport thereof, enabling customers and wholesalers to conveniently view and purchase those goods ]SECTION 71 - CANCELLED—
040Treatment in the nature of chemical processing of chemical, biochemical and pharmaceutical products for third parties [ ; consulting services relating to the treatment of chemical, biochemical and pharmaceutical products; information and advisory services in the field of chemical, biochemical and pharmaceutical products treatment and processing ]SECTION 71 - CANCELLED—
042Scientific research and development of pharmaceuticals; scientific and industrial research for the development of drugs and chemical components [ , as well as technical and scientific consultancy in the fields of scientific research of chemical, biochemical and pharmaceutical technologies; engineering services including engineering surveys in the fields of chemical, biochemical and pharmaceutical technologies; provision of technological professional knowledge, particularly in the field of planning and design of technological development in franchising chemical, biochemical and pharmaceutical products ]SECTION 71 - CANCELLED—
045Licensing in the field of chemical, biochemical and pharmaceutical products [ ; legal representation and advice, particularly before and during national procedures for the regulation of chemical, biochemical and pharmaceutical products ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 5, 2026INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Dec 15, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Nov 20, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 24, 2025INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Sep 27, 2025XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Sep 27, 2025XXCRGENERIC MADRID TRANSACTION CREATED—
May 23, 2025INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Apr 15, 2025NC71NOTICE OF CANCELLATION SEC. 71 E-MAILED—
Apr 15, 2025C71TCANCELLED SECTION 71—
Sep 30, 2024PR75POST REGISTRATION ACTION MAILED - SEC. 71 & 15—
Sep 16, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 19, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 21, 2023ES75TEAS SECTION 71 & 15 RECEIVED—
Jan 9, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 22, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 22, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 22, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 6, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 16, 2018XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Apr 16, 2018XXCRGENERIC MADRID TRANSACTION CREATED—
Apr 9, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 9, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 24, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 24, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 21, 2017GPNXNOTIFICATION PROCESSED BY IB—
Oct 4, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 4, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 4, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 18, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 18, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Sep 18, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 18, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 18, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 9, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 9, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 9, 2017ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Aug 16, 2017CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 15, 2017CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 26, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 26, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 20, 2017ALIEASSIGNED TO LIE—
Jun 15, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 8, 2017RFNTREFUSAL PROCESSED BY IB—
Mar 21, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 21, 2017RFRRREFUSAL PROCESSED BY MPU—
Mar 21, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 20, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 14, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 11, 2017DOCKASSIGNED TO EXAMINER—
Mar 10, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 9, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance